📈
📈 Business
Novo Nordisk Sues Eli Lilly Over Ads Comparing Weight-Loss Drugs
Novo Nordisk, maker of Ozempic, has filed a lawsuit against US rival Eli Lilly, alleging the company uses faulty data to compare the two firms' weight-loss and diabetes drugs in its advertising campaigns. The lawsuit centres on direct product comparisons in Eli Lilly's marketing materials.
Comments
No comments yet
Comments
No comments yet — be the first to weigh in 👇
No comments yet. Be the first!